Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05066126 · ClinicalTrials.gov registry record · NA
Mixed Presentation on Social Media
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 828
- Enrollment target
NCT05066126: Completed NA study, sponsored by University of Pennsylvania.
NCT05066126 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 828 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05066126, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 828 participants
- Enrollment target
Study Summary
This study is to understand how the presentation of information on social media influences processing and recall of information, particularly in relation to modified risk tobacco products. Participants will see a social media site where either (a) the topic of discussion varies between each post or (b) posts on the same topic are grouped together. They will then be asked to recall information about the posts they saw on the site.
Primary Outcome
Binary outcome as to whether the individual can recognize the specific text from a social media post as having appeared or not appeared on the social media site.
Interventions
- BEHAVIORAL Mixed-Presentation of Content
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 828 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2022-08-10 |
| Phase | NA |
What the finished NCT05066126 record still lists
NCT05066126 is an interventional study that assigns participants to a tested intervention. The registered 828 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower).
The record links to 0 conditions, and to 1 intervention - of which Mixed-Presentation of Content is the first listed.
NCT05066126 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05066126 about?
NCT05066126 is a clinical study titled "Mixed Presentation on Social Media". This study is to understand how the presentation of information on social media influences processing and recall of information, particularly in relation to modified risk tobacco products. Participants will see a social media site where either (a) the topic of discussion varies between each post or ...
What is the current status of trial NCT05066126?
This trial is currently completed. It is a NA study. The enrollment target is 828 participants. The study started on 2021-11-15. Estimated completion is 2022-08-10.
What interventions are being tested in trial NCT05066126?
The interventions under investigation include: Mixed-Presentation of Content (BEHAVIORAL).
Who is sponsoring clinical trial NCT05066126?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05066126's enrollment target sits among peer trials
828 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05124808 · 828 participants · NA
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
- NCT03547973 · 827 participants · Phase 2
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
- NCT05067283 · 830 participants · Phase 1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- NCT06592924 · 830 participants · Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI